Digital family program aims to curb diabetes and hypertension across europe

NCT ID NCT05648383

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested a 24-month program that combined face-to-face counseling with digital tools to help families prevent and manage type 2 diabetes and high blood pressure. Over 1,200 adults and their children from Albania, Bulgaria, Greece, and Spain took part. The program encouraged healthier lifestyles as a family, using mobile apps for self-monitoring and support. Researchers measured changes in blood sugar and blood pressure to see if the program worked better than standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

mHealth self-management intervention (behavioral)

What this could lead to

If successful, this could provide a scalable, family-centered digital approach to prevent and manage type 2 diabetes and hypertension, reducing the burden of these chronic conditions.

What could go wrong

This is a completed trial, but results are not yet widely published. The intervention is complex and may not be easily adopted in all communities. Long-term benefits beyond 24 months are unknown.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus hypertensive disorder Obesity obesity disorder Overweight prediabetes syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Harokopio University

    Athens, Attica, 17676, Greece

  • Medical University of Varna

    Varna, Varna, 9002, Bulgaria

  • Universidad de Zaragoza

    Zaragoza, Zaragoza, 50009, Spain

  • Universiteti i Mjekësisë

    Tirana, Rruga E Dibrës, AL1005, Albania